… Suppression of ovarian estrogen production reduces the recurrence of hormone-receptor–positive
early breast cancer in premenopausal women, but its value when added to tamoxifen …

… breast cancer in this study was found slightly more in postmenopausal women than in
premenopausal women… women in this study presented with breast cancer despite of high parity. …

… on other women residing in the same household as breast cancer cases were … woman
was randomly selected as a control for this study. Because of a small number of breast cancers …

… 739 premenopausal women with a breast cancer … cancers (n = 159) and 30 unconfirmed
breast cancer diagnoses, leaving 550 women with diagnoses of invasive premenopausal breast …

… in women with breast cancer and healthy controls; these studies suggested that women with
breast cancer … because of the small numbers of women studied and because the differences …

… Among premenopausal women with breast cancer, the addition of ovarian suppression to
… the recurrence of premenopausal estrogen-receptor–positive breast cancer, with increasing …

… rate of premenopausal breast cancer in the LDCs is indeed invariably lower than that in the
MDCs. However, the proportion of premenopausal breast cancer from total breast cancers is …

… In this study, we recruited 54 newly diagnosed premenopausal women with breast cancer
(BC) and 28 normal premenopausal women as control group (NC). There were no significant …

… of ER+ breast cancer among postmenopausal women. We previously … to breast cancer risk
among premenopausal women and that the association was stronger with ER+ breast cancer …

… 18 was identified but the data could not be retrieved; this study included 17 patients with
breast cancer and 67 matched controls in women who were premenopausal at blood collection. …